189 related articles for article (PubMed ID: 32395210)
1. Thalidomide for Patients with β-Thalassemia: A Multicenter Experience.
Yang K; Wu Y; Zhou Y; Long B; Lu Q; Zhou T; Wang L; Geng Z; Yin X
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020021. PubMed ID: 32395210
[TBL] [Abstract][Full Text] [Related]
2. Promising Response to Thalidomide in Symptomatic β-Thalassemia.
Yassin AK
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):337-341. PubMed ID: 32425386
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India.
Jain M; Chakrabarti P; Dolai TK; Ghosh P; Mandal PK; Baul SN; De R
Blood Cells Mol Dis; 2021 May; 88():102544. PubMed ID: 33610115
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
Ren Q; Zhou YL; Wang L; Chen YS; Ma YN; Li PP; Yin XL
Ann Hematol; 2018 Oct; 97(10):1933-1939. PubMed ID: 29931453
[TBL] [Abstract][Full Text] [Related]
5. [Predictors of Hematologic Responses in Patients with Non-Transfusion-Dependent β-Thalassemia Receiving Thalidomide Therapy].
Yang K; Yin XL; Liu XD; Hua F; Peng W; Li L; Chen K; Zhang J; Luo S; Xiao J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1519-1526. PubMed ID: 36208259
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Efficacy and Safety of Thalidomide for Treating Patients With
Lu Y; Wei Z; Yang G; Lai Y; Liu R
Front Pharmacol; 2021; 12():814302. PubMed ID: 35087410
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.
Ali Z; Ismail M; Rehman IU; Rani GF; Ali M; Khan MTM
Sci Rep; 2023 Aug; 13(1):13592. PubMed ID: 37604857
[TBL] [Abstract][Full Text] [Related]
8. The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
Yang K; Wu Y; Ma Y; Xiao J; Zhou Y; Yin X
Blood Cells Mol Dis; 2020 Sep; 84():102442. PubMed ID: 32387854
[TBL] [Abstract][Full Text] [Related]
9. Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
Bhurani D; Kapoor J; Yadav N; Khushoo V; Agrawal N; Ahmed R; Arora JS; Mehta P
Ann Hematol; 2021 Jun; 100(6):1417-1427. PubMed ID: 33811502
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study.
Li X; Hu S; Liu Y; Huang J; Hong W; Xu L; Xu H; Fang J
Front Pharmacol; 2021; 12():722502. PubMed ID: 34456732
[No Abstract] [Full Text] [Related]
11. Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia.
Piga A; Longo F; Gamberini MR; Voskaridou E; Ricchi P; Caruso V; Pietrangelo A; Zhang X; Shetty JK; Attie KM; Tartaglione I
Ther Adv Hematol; 2022; 13():20406207221134404. PubMed ID: 36505885
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.
Chen JM; Zhu WJ; Liu J; Wang GZ; Chen XQ; Tan Y; Xu WW; Qu LW; Li JY; Yang HJ; Huang L; Cai N; Wang WD; Huang K; Xu JQ; Li GH; He S; Luo TY; Huang Y; Liu SH; Wu WQ; Lu QY; Zhou MG; Chen SY; Li RL; Hu ML; Huang Y; Wei JH; Li JM; Chen SJ; Zhou GB
Signal Transduct Target Ther; 2021 Nov; 6(1):405. PubMed ID: 34795208
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Thalidomide in Patients With Transfusion-Dependent Thalassemia.
Chandra J; Parakh N; Sidharth ; Singh N; Sharma S; Goel M; Pemde H
Indian Pediatr; 2021 Jul; 58(7):611-616. PubMed ID: 34315832
[TBL] [Abstract][Full Text] [Related]
14. A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients.
Bhattacharjee U; Khadwal A; Shafiq N; Lad D; Sharma P; Das R; Shukla P; Jain A; Prakash G; Malhotra P
Indian J Hematol Blood Transfus; 2023 Apr; 39(2):266-275. PubMed ID: 36620489
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Thalidomide and Hydroxyurea Combination in Beta Thalassemia Patients.
Garg A; Patel K; Shah K; Trivedi D; Raj A; Yadav R; Shah S
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):85-89. PubMed ID: 36699430
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide has a significant effect in patients with thalassemia intermedia.
Li Y; Ren Q; Zhou Y; Li P; Lin W; Yin X
Hematology; 2018 Jan; 23(1):50-54. PubMed ID: 28718348
[TBL] [Abstract][Full Text] [Related]
17. The long-term efficacy in blood transfusions, hematologic parameter changes, and complications after splenectomy in patients with transfusion-dependent thalassemia.
Osataphan N; Dumnil S; Tantiworawit A; Punnachet T; Hantrakun N; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Fanhchaksai K; Charoenkwan P
Transfus Apher Sci; 2023 Jun; 62(3):103620. PubMed ID: 36509632
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.
Chuansumrit A; Sirachainan N; Kitpoka P; Kadegasem P; Songdej D; Sasanakul W; Wongwerawattanakoon P
Hemoglobin; 2019; 43(4-5):264-272. PubMed ID: 31760834
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia.
Ansari SH; Ansari I; Wasim M; Sattar A; Khawaja S; Zohaib M; Hussain Z; Adil SO; Ansari AH; Ansari UH; Farooq F; Masqati NU
Blood Adv; 2022 Dec; 6(24):6162-6168. PubMed ID: 35477175
[TBL] [Abstract][Full Text] [Related]
20. The association between pre-transfusion hemoglobin levels and thalassemia complications.
Wanchaitanawong W; Tantiworawit A; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Niprapan P; Fanhchaksai K; Charoenkwan P
Hematology; 2021 Dec; 26(1):1-8. PubMed ID: 33357151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
